The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.

DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ rating on the stock and a $106 price target. The research firm reiterated ...

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The ...

A class action lawsuit has been filed against Dexcom (Nasdaq:DXCM) in the U.S. District Court for the Central District of California.

To remove a stuck DeWalt battery, use the release tab, apply silicone spray, or clear debris around the terminals to free the ...

Analysts have set 12-month price targets for DexCom, revealing an average target of $97.15, a high estimate of $106.00, and a ...

Go back to Settings > System and scroll down until you find the "Developer options" entry. Tap that entry. Scroll down until you find the "Quick settings developer tiles" entry and tap it. On the ...

San Diego-based Dexcom Inc., is the target of a class action lawsuit in U.S. district court over the company’s G7 continuous glucose monitors, an action which follows a U.S. FDA warning letter by a ...

"New Mexico will become the first state in the country to provide free universal child care regardless of income as of ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A ...